Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men

George J. Greene; Greg Swann; Angela J. Fought; Alex Carballo-Diéguez; Thomas J. Hope; Patrick F. Kiser; Brian Mustanski; Richard T. D’Aquila

doi:10.1007/s10461-016-1565-9

Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men

George J. Greene, Greg Swann, Angela J. Fought, Alex Carballo-Diéguez, Thomas J. Hope, Patrick F. Kiser, Brian Mustanski, Richard T. D’Aquila^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

105 Scopus citations

Abstract

HIV prevention method preferences were evaluated among 512 U.S. men who have sex with men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option across pairwise comparisons of condoms, daily oral pre-exposure prophylaxis (PrEP), and long-acting PrEP delivered via either an injectable or one of two types of PrEP implants differing in visibility. Condoms were most frequently preferred (33.8 %), followed by non-visible implants (21.5 %), and oral PrEP (17.0 %); HIV risk was reported by more choosing implants. In a follow-up question comparing the four PrEP options only, daily oral pills and non-visible implants were most frequently preferred (35.5 and 34.3 %, respectively), followed by injections (25.2 %) and visible implants (4.3 %). An inductive, open-coding approach determined that convenience, duration of protection, and privacy were the most commonly cited reasons for a PrEP method choice, and associated with self-report of HIV risk. Tailoring PrEP product development to privacy and other concerns important to those at highest HIV risk may improve HIV prevention.

Original language	English (US)
Pages (from-to)	1336-1349
Number of pages	14
Journal	AIDS and behavior
Volume	21
Issue number	5
DOIs	https://doi.org/10.1007/s10461-016-1565-9
State	Published - May 1 2017

Funding

Northwestern University Feinberg School of Medicine and Northwestern Medicine supported this research. The National Institute of Allergy and Infectious Diseases of the National Institutes of Health funded preparation of this manuscript under award number UM1 AI120184. The authors appreciate the Northwestern University infrastructure support provided by the IMPACT LGBT Health and Development Program and the Third Coast Center for AIDS Research, an NIH-funded center (P30 AI 117943). This research could not have been conducted without research staff support from Antonia Clifford, Krystal Madkins, and Dan Ryan. We also appreciate expert marketing consulting advice from Robert Schieffer and critical manuscript review by Rebecca Giguere.

Keywords

HIV
Homosexuality
Male
Pre-exposure prophylaxis
Prevention
Sexual behavior

ASJC Scopus subject areas

Social Psychology
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10461-016-1565-9

Cite this

@article{943d30e8cadf456b8ffc81525a185a60,

title = "Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men",

abstract = "HIV prevention method preferences were evaluated among 512 U.S. men who have sex with men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option across pairwise comparisons of condoms, daily oral pre-exposure prophylaxis (PrEP), and long-acting PrEP delivered via either an injectable or one of two types of PrEP implants differing in visibility. Condoms were most frequently preferred (33.8 %), followed by non-visible implants (21.5 %), and oral PrEP (17.0 %); HIV risk was reported by more choosing implants. In a follow-up question comparing the four PrEP options only, daily oral pills and non-visible implants were most frequently preferred (35.5 and 34.3 %, respectively), followed by injections (25.2 %) and visible implants (4.3 %). An inductive, open-coding approach determined that convenience, duration of protection, and privacy were the most commonly cited reasons for a PrEP method choice, and associated with self-report of HIV risk. Tailoring PrEP product development to privacy and other concerns important to those at highest HIV risk may improve HIV prevention.",

keywords = "HIV, Homosexuality, Male, Pre-exposure prophylaxis, Prevention, Sexual behavior",

author = "Greene, {George J.} and Greg Swann and Fought, {Angela J.} and Alex Carballo-Di{\'e}guez and Hope, {Thomas J.} and Kiser, {Patrick F.} and Brian Mustanski and D{\textquoteright}Aquila, {Richard T.}",

note = "Publisher Copyright: {\textcopyright} 2016, Springer Science+Business Media New York.",

year = "2017",

month = may,

day = "1",

doi = "10.1007/s10461-016-1565-9",

language = "English (US)",

volume = "21",

pages = "1336--1349",

journal = "AIDS and behavior",

issn = "1090-7165",

publisher = "Springer New York",

number = "5",

}

TY - JOUR

T1 - Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men

AU - Greene, George J.

AU - Swann, Greg

AU - Fought, Angela J.

AU - Carballo-Diéguez, Alex

AU - Hope, Thomas J.

AU - Kiser, Patrick F.

AU - Mustanski, Brian

AU - D’Aquila, Richard T.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - HIV prevention method preferences were evaluated among 512 U.S. men who have sex with men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option across pairwise comparisons of condoms, daily oral pre-exposure prophylaxis (PrEP), and long-acting PrEP delivered via either an injectable or one of two types of PrEP implants differing in visibility. Condoms were most frequently preferred (33.8 %), followed by non-visible implants (21.5 %), and oral PrEP (17.0 %); HIV risk was reported by more choosing implants. In a follow-up question comparing the four PrEP options only, daily oral pills and non-visible implants were most frequently preferred (35.5 and 34.3 %, respectively), followed by injections (25.2 %) and visible implants (4.3 %). An inductive, open-coding approach determined that convenience, duration of protection, and privacy were the most commonly cited reasons for a PrEP method choice, and associated with self-report of HIV risk. Tailoring PrEP product development to privacy and other concerns important to those at highest HIV risk may improve HIV prevention.

AB - HIV prevention method preferences were evaluated among 512 U.S. men who have sex with men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option across pairwise comparisons of condoms, daily oral pre-exposure prophylaxis (PrEP), and long-acting PrEP delivered via either an injectable or one of two types of PrEP implants differing in visibility. Condoms were most frequently preferred (33.8 %), followed by non-visible implants (21.5 %), and oral PrEP (17.0 %); HIV risk was reported by more choosing implants. In a follow-up question comparing the four PrEP options only, daily oral pills and non-visible implants were most frequently preferred (35.5 and 34.3 %, respectively), followed by injections (25.2 %) and visible implants (4.3 %). An inductive, open-coding approach determined that convenience, duration of protection, and privacy were the most commonly cited reasons for a PrEP method choice, and associated with self-report of HIV risk. Tailoring PrEP product development to privacy and other concerns important to those at highest HIV risk may improve HIV prevention.

KW - HIV

KW - Homosexuality

KW - Male

KW - Pre-exposure prophylaxis

KW - Prevention

KW - Sexual behavior

UR - http://www.scopus.com/inward/record.url?scp=84992154227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992154227&partnerID=8YFLogxK

U2 - 10.1007/s10461-016-1565-9

DO - 10.1007/s10461-016-1565-9

M3 - Article

C2 - 27770215

AN - SCOPUS:84992154227

SN - 1090-7165

VL - 21

SP - 1336

EP - 1349

JO - AIDS and behavior

JF - AIDS and behavior

IS - 5

ER -

Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this